Overview of Dr. Dixon
Dr. Matthew Dixon is a Hepatopancreatobiliary surgeon in Chicago, IL and is affiliated with Rush University Medical Center. He has a passion and interest in the clinical treatment of patients with cancers of the liver, metastatic disease of the liver (such as metastatic colorectal cancer), benign liver tumors, bile duct cancer, pancreatic cancer, pancreatic cysts, neuroendocrine tumors and other types of rare pancreatic tumors.
Office
1725 W Harrison St, Suite 810
Chicago, IL 60614Fax+1 312-563-2775
Education & Training
- Maimonides Medical CenterResidency, Surgery, 2009 - 2014
- St. George's University School of MedicineClass of 2009
Certifications & Licensure
- IL State Medical License 2022 - 2026
- IN State Medical License 2022 - 2025
- PA State Medical License 2018 - 2023
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 17 citationsThe Future Liver Remnant: Definition, Evaluation, and ManagementMatthew Dixon, Jeffrey Cruz, Nabeel Sarwani, Niraj J. Gusani
The American Surgeon. 2021-02-01 - 8 citationsAdjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology.Elizabeth J. Olecki, Kelly A. Stahl, Madeline B. Torres, June S. Peng, Matthew Dixon
Annals of Surgical Oncology. 2021-01-31 - 1 citationsPrediction of post-hepatectomy liver failure by preoperative gadoxetate disodium-enhanced magnetic resonance imaging.Johannes C Lauscher, Matthew E B Dixon, George Jada, Mariam Afshin, Konrad Neumann
HPB. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: